256
Participants
Start Date
Not specified
Study Completion Date
March 31, 1998
Lamivudine
Stavudine
Zidovudine
Didanosine
Beth Israel Med. Ctr. (Mt. Sinai), New York
NYU Med. Ctr., Dept. of Medicine, New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Johns Hopkins Adult AIDS CRS, Baltimore
Univ. of Miami AIDS CRS, Miami
The Ohio State University Medical Center, Columbus
MetroHealth CRS, Cleveland
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Methodist Hosp. of Indiana, Indianapolis
Cook County Hosp. CORE Ctr., Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Weiss Memorial Hosp., Chicago
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
University of Colorado Hospital CRS, Aurora
UCLA CARE Center CRS, Los Angeles
Ucsd, Avrc Crs, San Diego
Stanford CRS, Palo Alto
Santa Clara Valley Med. Ctr., San Jose
Queens Med. Ctr., Honolulu
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
University of Washington AIDS CRS, Seattle
Alabama Therapeutics CRS, Birmingham
San Mateo County AIDS Program, San Mateo
Northwestern University CRS, Chicago
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
Washington U CRS, St Louis
Univ. of Rochester ACTG CRS, Rochester
Unc Aids Crs, Chapel Hill
Carolinas HealthCare System, Carolinas Med. Ctr., Charlotte
Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro
Puerto Rico-AIDS CRS, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH